Effects of somatostatin on splanchnic hemodynamics and plasma glucagon in portal hypertensive rats.

No abstract is available for this paper.

• Publication year

  1988

• Venue

  American Journal of Physiology

• Publication date

  1988-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1152/AJPGI.1988.254.3.G322PMID 2894777
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Splanchnic and systemic hemodynamics in portal hypertensive rats during hemorrhage and blood volume restitution.

  1986cited by this paper
• Renal hyperemia in portal hypertension is not mediated by gastrointestinal peptides.

  1986cited by this paper
• Role of glucagon in splanchnic hyperemia of chronic portal hypertension.

  1986cited by this paper
• Effects of somatostatin on hepatic haemodynamics in the cirrhotic rat.

  1986cited by this paper
• Increased portal venous resistance hinders portal pressure reduction during the administration of β‐adrenergic blocking agents in a portal hypertensive model

  1985cited by this paper
• Hemodynamic studies in a parabiotic model of portal hypertension

  1985cited by this paper
• "Forward" and "backward" flow mechanisms of portal hypertension. Relative contributions in the rat model of portal vein stenosis.

  1985cited by this paper
• Humoral factors may mediate increased rat hindquarter blood flow in portal hypertension.

  1985cited by this paper
• Evolution of portal hypertension and mechanisms involved in its maintenance in a rat model.

  1985cited by this paper
• Effect of exogenous somatostatin infusion on gastrointestinal blood flow and hormones in the conscious dog.

  1985cited by this paper
• A prospective randomised controlled clinical trial comparing somatostatin and vasopressin in controlling acute variceal haemorrhage.

  1985cited by this paper
• Reduced vascular sensitivity to norepinephrine in portal-hypertensive rats.

  1985cited by this paper
• Role of humoral factors in the intestinal hyperemia associated with chronic portal hypertension.

  1984cited by this paper
• Comparison of Intravenous Somatostatin and Vasopressin Infusions in Treatment of Acute Variceal Hemorrhage

  1984cited by this paper
• Portal-systemic shunting and the hemodynamic effects of nitroglycerin in the rat.

  1984cited by this paper
• Venospastic activity of somatostatin in vivo in man: naloxone reversible tachyphylaxis.

  1984cited by this paper
• Hyperdynamic circulation in portal-hypertensive rat model: a primary factor for maintenance of chronic portal hypertension.

  1983cited by this paper
• Changes in splanchnic blood flow in portal hypertensive rats

  1982cited by this paper
• Splanchnic hemodynamics in portal-hypertensive rats: measurement with gamma-labeled microspheres.

  1982cited by this paper
• Somatostatin-28 is longer acting and more selective than somatostatin-14 on pituitary and pancreatic hormone release.

  1982cited by this paper
• Measurement of portal-systemic shunting in the rat by using gamma-labeled microspheres.

  1981cited by this paper
• Effects of somatostatin on hepatic and systemic hemodynamics in patients with cirrhosis of the liver: comparison with vasopressin.

  1981cited by this paper
• Liver blood flow. I. Intrinsic and nervous control of liver blood flow.

  1981cited by this paper
• Vasoactive intestinal polypeptide (VIP) in cirrhosis: arteriovenous extraction in different vascular beds.

  1980cited by this paper
• Reference sample microsphere method: cardiac output and blood flows in conscious rat.

  1980cited by this paper
• The effect of somatostatin on the hepatic extraction of insulin and glucagon in the anesthetized dog.

  1980cited by this paper
• Circulatory effects of somatostatin in anaesthetized dogs.

  1979cited by this paper
• Reduction in Portal Vein Blood Flow by Somatostatin

  1979cited by this paper
• Circulatory effects of somatostatin in anesthetized man.

  1979cited by this paper
• Hypergastrinaemia in cirrhosis of liver.

  1976cited by this paper
• THE INHIBITION BY GLUCAGON OF THE VASOCONSTRICTOR ACTIONS OF NORADRENALINE, ANGIOTENSIN AND VASOPRESSIN ON THE HEPATIC ARTERIAL VASCULAR BED OF THE DOG

  1976cited by this paper
• Inhibition of gastrin and gastric-acid secretion by growth-hormone release-inhibiting hormone.

  1974cited by this paper
• Hemodynamic Responses to Glucagon: An Experimental Study of Central, Visceral and Peripheral Effects

  1970cited by this paper

• Emerging Therapeutic Targets for Portal Hypertension

  2023cites this paper
• Selective somatostatin receptor 5 inhibition improves hepatic insulin sensitivity

  2022cites this paper
• Somatostatin and the “Small-For-Size” Liver

  2019cites this paper
• Molecular Mechanisms Leading to Splanchnic Vasodilation in Liver Cirrhosis

  2017cites this paper
• Somatostatin Therapy Protects Porcine Livers in Small‐for‐Size Liver Transplantation

  2014cites this paper
• Somatostatin in Acute Bleeding Oesophageal Varices

  2012cites this paper
• Esophageal Varices: Pathophysiology, Approach, and Clinical Dilemmas

  2012cites this paper
• A . Treatment of Acute Variceal Haemorrhage

  2012cites this paper
• Pathophysiology of Portal Hypertension and Esophageal Varices

  2012cites this paper
• Spectrum of colonic mucosal abnormalities in patients with cirrhosis and portal hypertension : An Endoscopic study.

  2011cites this paper
• Portal Hypertension: Extrahepatic Mechanisms

  2011cites this paper
• Characterization and prevention of the “small-for-size” syndrome in a porcine model of hepatic transplant

  2011cites this paper
• Vapreotide: a somatostatin analog for the treatment of acute variceal bleeding

  2009cites this paper
• Intimal Hyperplasia in Rats after Subcutaneous Injection of a Somatostatin Analog

  2009cites this paper
• Effect of early bosentan administration on the development of esophageal varices in cirrhotic rats: experimental study in Wistar rats

  2008cites this paper
• Early Propranolol Administration Does Not Prevent Development of Esophageal Varices in Cirrhotic Rats

  2008cites this paper
• Short-term cardiovascular effects of somatostatin in patients with cirrhosis.

  2008cites this paper
• Vapreotide acetate for the treatment of esophageal variceal bleeding

  2008cites this paper
• Short- and long-term hemodynamic response to octreotide in portal hypertensive patients: a double-blind, controlled study.

  2008cites this paper
• Vascular actions of the prostacyclin receptor antagonist BAY 73-1449 in the portal hypertensive rat.

  2008cites this paper
• Octreotide Enhances Portal Pressure Reduction Induced by Propranolol in Cirrhosis: A Randomized, Controlled Trial

  2007cites this paper
• Influence of somatostatin and octreotide on liver microcirculation in an experimental mouse model of cirrhosis studied by intravital fluorescence microscopy

  2007cites this paper
• Mecanismes involucrats en la regulació del to vascular hepàtic en la cirrosi: Paper dels prostanoids vasoconstrictors i de l'estrès oxidatiu

  2007cites this paper
• Attenuation of acute phase shear stress by somatostatin improves small‐for‐size liver graft survival

  2006cites this paper
• Effects of propranolol on venous compliance in conscious rats with pre-hepatic portal hypertension.

  2006cites this paper
• Lanreotide on Collateral Response to Endothelin‐1 and Vasopressin in Cirrhotic Rats

  2006cites this paper
• Portal hypertension: from pathophysiology to clinical practice

  2005cites this paper
• Pharmacologic Therapy for Management of Esophageal Varices

  2005cites this paper
• Effects of somatostatin, terlipressin and somatostatin plus terlipressin on portal and systemic hemodynamics and renal sodium excretion in patients with cirrhosis

  2005cites this paper
• The effect of octreotide on fasting and postprandial splanchnic hemodynamics in cirrhosis.

  2004cites this paper
• Componente funcional de la hipertensión portal

  2004cites this paper
• Hemodynamic Effects of Acute and Chronic Administration of Vapreotide in Rats with Cirrhosis

  2004cites this paper
• [Functional component of portal hypertension].

  2004cites this paper
• Effect of neonatal capsaicin treatment on haemodynamics and renal function in cirrhotic rats

  2003cites this paper
• Role of acute elevation of portal venous pressure by exogenous glucagon on gastric mucosal injury in rats with portal hypertension.

  2003cites this paper
• Effects of the V1a vasopressin agonist F‐180 on portal hypertension‐related bleeding in portal hypertensive rats

  2003cites this paper
• Tratamientos combinados de las varices esofágicas

  2003cites this paper
• Pharmacological rationale for the use of somatostatin and analogues in portal hypertension

  2003cites this paper
• Effekte von Somatostatin auf den portalen Druck und den portalen Blutfluss bei Patienten mit Pfortaderhochdruck aufgrund einer Leberzirrhose

  2003cites this paper
• Effects of somatostatin and octreotide on portal-systemic collaterals in portal hypertensive rats.

  2002cites this paper
• Nitric Oxide and Portal Hypertension

  2002cites this paper
• La somatostatina en el tratamiento de la hemorragia aguda por varices

  2002cites this paper
• Total effective vascular compliance in patients with cirrhosis. Effects of propranolol.

  2002cites this paper
• Algies vasculaires de la face associées à une acromégalie et soulagées par la somatostatine

  2002cites this paper
• The effect of insulin and glucagon on splanchnic oxygen consumption.

  2002cites this paper
• The effect of prostacyclin on the gastric mucosa in portal-hypertensive rats.

  2002cites this paper
• Octreotide potentiates PKC-dependent vasoconstrictors in portal-hypertensive and control rats.

  2001cites this paper
• 49 – Portal Hypertension and Portacaval Shunt*

  2001cites this paper
• Haemodynamic effects of propranolol, octreotide and their combination during fasting and post-prandial splanchnic hyperaemia in patients with cirrhosis

  2001cites this paper
• Bolus somatostatin but not octreotide reduces hepatic sinusoidal pressure by a NO‐independent mechanism in chronic liver disease

  2001cites this paper
• Somatostatin suppresses endothelin-1-induced rat hepatic stellate cell contraction via somatostatin receptor subtype 1.

  2001cites this paper
• The role of portal pressure in the severity of bleeding in portal hypertensive rats

  2000cites this paper
• Complications of cirrhosis. I. Portal hypertension.

  2000cites this paper
• Pathophysiology of Portal Hypertension

  2000cites this paper
• Local arterial vasoconstriction induced by octreotide in patients with cirrhosis

  2000cites this paper
• Portal hypertension: state of the art.

  1999cites this paper
• Influence of Pharmacological Agents on Portal Hemodynamics: Basis for Its Use in the Treatment of Portal Hypertension

  1999cites this paper
• Effects of sustained-release lanreotide on hemodynamics in rats with portal vein stenosis.

  1999cites this paper
• Effects of Different Octreotide Dosages on Splanchnic Hemodynamics and Glucagon in Healthy Volunteers

  1999cites this paper
• Doppler evaluation of the effects of pharmacological treatment of portal hypertension.

  1999cites this paper
• Somatostatin and octreotide modulate the function of Kupffer cells in liver cirrhosis.

  1999cites this paper
• Hyperkinetic circulation and decreased sensitivity to vasoconstrictors following portacaval shunt in the rat. Effects of chronic nitric oxide inhibition.

  1999cites this paper
• Effect of long-term octreotide and isosorbide dinitrate on haemodynamics in rats with portal vein stenosis.

  1998cites this paper
• Development of analogues: successes and failures.

  1998cites this paper
• Somatostatin for acute severe bleeding from portal hypertensive gastropathy

  1998cites this paper
• Effects of F‐180, a new selective vasoconstrictor peptide, compared with terlipressin and vasopressin on systemic and splanchnic hemodynamics in a rat model of portal hypertension

  1998cites this paper
• Haemodynamic responses to a combination of terlipressin and octreotide in portal hypertensive rats

  1997cites this paper
• Altered vascular norepinephrine responses in portal hypertensive intestine: role of PKA and guanylate cyclase.

  1997cites this paper
• Vascular actions of octreotide in the portal hypertensive rat

  1997cites this paper
• Octreotide long-term treatment in patients with portal hypertension: persistent inhibition of postprandial glucagon response without major changes in renal function.

  1997cites this paper
• Effects of glucagon on superior mesenteric artery and femoral artery haemodynamics in humans.

  1997cites this paper
• Portal hypertensive colopathy in patients with cirrhosis.

  1996cites this paper
• Regional differences in nitric oxide-dependent vascular responses to somatostatin.

  1996cites this paper
• Management of portal hypertension and its complications.

  1996cites this paper
• Chronic administration of octreotide increases vascular responsiveness in rats with portal hypertension.

  1996cites this paper
• Mechanical pumping of portal blood to the liver: hemodynamic effects of a new experimental treatment for portal hypertension.

  1996cites this paper
• Role of nitric oxide in hyporeactivity to noradrenaline of isolated aortic rings in portal hypertensive rats.

  1995cites this paper
• Somatostatin attenuates the hyperdynamic circulatory state in the gastric mucosa of rats with portal hypertension.

  1995cites this paper
• Cardiovascular effects of octreotide in patients with hepatic cirrhosis

  1995cites this paper
• [The gastropathy of portal hypertension].

  1995cites this paper
• Effects of bolus injections and continuous infusions of somatostatin and placebo in patients with cirrhosis: A double‐blind hemodynamic investigation

  1995cites this paper
• Local control of veins: biomechanical, metabolic, and humoral aspects.

  1995cites this paper
• Impaired function of pancreatic islets from rats with portal hypertension resulting from cirrhosis and partial portal vein ligation

  1994cites this paper
• Prostacyclin production in acute, chronic, and long-term experimental portal hypertension.

  1994cites this paper
• Circadian variations of portal pressure and variceal hemorrhage in patients with cirrhosis

  1994cites this paper
• Effect of bolus injection and continuous infusion of somatostatin on gastric perfusion in cirrhotic patients with portal‐hypertensive gastropathy

  1994cites this paper
• Glucagon in portal hypertension.

  1994cites this paper
• Effects of continued NO inhibition on portal hypertensive syndrome after portal vein stenosis in rat.

  1994cites this paper
• A prospective randomized trial comparing somatostatin and sclerotherapy in the treatment of acute variceal bleeding

  1994cites this paper
• [Role of nitric oxide in alterations of the systemic and splanchnic hemodynamics in a experimental model of portal hypertension].

  1994cites this paper
• Organic nitrates in portal hypertension.

  1994cites this paper
• The effect of different doses of a bolus injection of somatostatin combined with a slow infusion on transmural oesophageal variceal pressure in patients with cirrhosis.

  1994cites this paper
• Involvement of nitric oxide and prostaglandins in gastric mucosal hyperemia of portal‐hypertensive anesthetized rats

  1993cites this paper
• Octreotide ameliorates vasodilatation and Na+ retention in portal hypertensive rats.

  1993cites this paper
• Peptidergic Regulation of Gastrointestinal Blood Flow

  1993cites this paper
• Effects of ritanserin, a selective and specific S2‐serotonergic antagonist, on portal pressure and splanchnic hemodynamics in rats with long‐term bile duct ligation

  1993cites this paper
• Gastrointestinal Regulatory Peptides

  1993cites this paper
• Endogenous vasoconstrictor tone in intestine of normal and portal hypertensive rats.

  1993cites this paper
• Bleeding Gastroesophageal Varices

  1993cites this paper
• Changes of hepatic and systemic haemodynamics following somatostatin administration in patients with hepatitis B‐related cirrhosis

  1993cites this paper